alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed).                    

*Date:*                         July 25-27, 2022.                    

*Time:*                         7:00 a.m. to 3:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F21B, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Maryam Feili-Hariri, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F21B, Rockville, MD 20852, (240) 669-5026,                         *haririmf@niaid.nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: June 23, 2022.

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-13797 Filed 6-28-22; 8:45 am]

BILLING CODE 4140-01-P
To the Shareholders and Board of Directors of
Smith Barney Aggressive Growth Fund Inc.:

In planning and performing our audit of the financial statements
of Smith Barney Aggressive Growth Fund Inc. (the "Fund") for the
year ended August 31, 1997, we considered its internal control
structure, including procedures for safeguarding securities, in
order to determine our auditing procedures for the purpose of
expressing our opinion on the financial statements and to comply
with the requirements of Form N-SAR, not to provide assurance on
the internal control structure.

The management of the Fund is responsible for establishing and
maintaining an internal control structure.  In fulfilling this
responsibility, estimates and judgments by management are
required to assess the expected benefits and related costs of
internal control structure policies and procedures.  Two of the
objectives of an internal control structure are to provide
management with reasonable, but not absolute, assurance that
assets are safeguarded against loss from unauthorized use or
disposition and that transactions are executed in accordance with
management's authorization and recorded properly to permit
preparation of financial statements in conformity with generally
accepted accounting principles.

Because of inherent limitations in any internal control
structure, errors or irregularities may occur and not be
detected.  Also, projection of any evaluation of the structure to
future periods is subject to the risk that it may become
inadequate because of changes in conditions or that the
effectiveness of the design and operation may deteriorate.

Our consideration of the internal control structure would not
necessarily disclose all matters in the internal control
structure that might be material weaknesses under standards
established by the American Institute of Certified Public
Accountants.  A material weakness is a condition in which the
design or operation of the specific internal control structure
elements does not reduce to a relatively low level the risk that
errors or irregularities in amounts that would be material in
relation to the financial statements being audited may occur and
not be detected within a timely period by employees in the normal
course of performing their assigned functions.  However, we noted
no matters involving the internal control structure, including
procedures for safeguarding securities, which we consider to be
material weaknesses as defined above as of August 31, 1997.

This report is intended solely for the information and use of
management and the Securities and Exchange Commission.




October 15, 1997
Exhibit 32

CERTIFICATION PURSUANT TO  18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Bristol West Holdings, Inc. (the "Company") on Form 10-Q for the period ending
March 31, 2004, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, James R. Fisher and Randy D. Sutton, Chief Executive Officer and Chief Financial
Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge:

|May 13, 2004                                                           |  |                                                                                     |  | 
|---------------------------------------------------------------------- |  | ----------------------------------------------------------------------------------- |  | 
|/s/JAMES R. FISHERJames R. Fisher
Chairman and Chief Executive Officer |  | /s/RANDY D. SUTTONRandy D. Sutton
Senior Vice President and Chief Financial Officer |  | 

---



QuickLinks
Exhibit 32.2



CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER



In connection with the accompanying Annual Report on Form 10-K for the year ended December 31, 2004 (the Periodic Report), I, T.
Kevin DeNicola, Senior Vice President and Chief Financial Officer of Millennium Chemicals Inc., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(1) | the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. Section 78m or 78o(d)); and
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) | the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of Millennium Chemicals Inc.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |                                                  
|-------------------- |  | -------------------------------------------------
|Date: March 16, 2005 |  | /s/ T. Kevin DeNicola                            
|                     |  | T. Kevin DeNicola                                
|                     |  | Senior Vice President and Chief Financial Officer



A signed original of this written
statement required by Section 906 has been provided to Millennium Chemicals Inc. and will be retained by Millennium Chemicals Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
# Delegation of Authority Under Section 506(a)(1) of the Foreign Assistance Act of 1961

# Memorandum for the Secretary of State

By the authority vested in me as President by the Constitution and the laws of the United States of America, including section 621 of the Foreign Assistance Act of 1961 (FAA), I hereby delegate to the Secretary of State the authority under section 506(a)(1) of the FAA to direct the drawdown of up to an aggregate value of $350 million in defense articles and services of the Department of Defense, and military education and training, to provide assistance to Ukraine and to make the determinations required under such section to direct such a drawdown.

                        You are authorized and directed to publish this memorandum in the                         *Federal Register*.                    

[FR Doc. 2022-13745

Billing code 4710-10-P
**EXHIBIT 31.1**

 

#### **CERTIFICATIONS**

#### ** **

I, Dana Persson, certifythat:

 

1.             I have reviewed this Quarterly Report on Form 10-Qof Golden Oval Eggs, LLC;

 

2.             Based on my knowledge, this report doesnot contain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the periodcovered by this report;

 

3.             Based on my knowledge, the financialstatements, and other financial information included in this report, fairlypresent in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in thisreport;

 

4.             The registrant’s other certifying officer(s) andI are responsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))for the registrant and have:

 

(a)          Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designedunder our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisreport is being prepared;

 

(b)         Evaluated the effectiveness of theregistrant’s disclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosure controls andprocedures, as of the end of the period covered by this report based on suchevaluation; and

 

(c)          Disclosed in this report any change inthe registrant’s internal control over financial reporting that occurred duringthe registrant’s most recent fiscal quarter (the registrant’s fourth fiscalquarter in the case of an annual report) that has materially affected, or isreasonably likely to materially affect, the registrant’s internal control overfinancial reporting; and

 

5.             The registrant’s other certifying officer(s) andI have disclosed, based on our most recent evaluation of internal control overfinancial reporting, to the registrant’s auditors and the audit committee ofthe registrant’s board of directors (or persons performing the equivalentfunctions):

 

(a)          All significant deficiencies and materialweaknesses in the design or operation of internal control over financialreporting which are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financial information; and

 

(b)         Any fraud, whether or not material, thatinvolves management or other employees who have a significant role in theregistrant’s internal control over financial reporting.

 

 

Date:      April 14 , 2008

 

 
|   | /s/ Dana Persson                       |
|--------|----------------------------------------|
|   | Dana Persson                           |
|   | President and Chief  Executive Officer |

 

----
EXHIBIT 32

                      CERTIFICATION PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002

         The undersigned, John M. Sharpe, Jr., hereby certifies as follows:

         1. I am the Chief Executive Officer and Chief Financial Officer, of
Inner Systems, Inc. (the "Company").

         2. To the best of my knowledge, the Company's Quarterly Report on Form
10-QSB for the quarter ended June 30, 2006 (the "Report") complies in all
material respects with the requirements of Section 13(a) of the Securities
Exchange Act of 1934, as amended.

         3. To the best of my knowledge based upon a review of the Report, the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company for the period
audited.


         SIGNATURE                        TITLE                       DATE
         ---------                        -----                       ----

/s/ John M. Sharpe, Jr.        President, Chief Executive
-----------------------        Officer and Chief Financial       August 20, 2007
JOHN M. SHARPE, JR.            Officer
VIA EDGAR  
  
  
  
November 25, 1996  
  
Securities and Exchange Commission  
450 Fifth Street, N.W.  
Washington, D.C. 20549  
  
RE:	Smith Barney Concert Series Inc.  
	File Nos. 33-64457  
		   811-7435  
  
Dear Sirs:  
  
Pursuant to Rule 497(j) under the Securities Act of 1933, as amended, 
please   
accept this letter as certification that the Prospectus and Statement of   
Additional Information for the above-referenced fund (the "Fund") does 
not   
differ from that contained in Post-Effective Amendment No. 5 to the 
Fund's   
Registration Statement on Form N-1A, which was filed electronically on   
November 19, 1996.    
  
Please return an electronic transmittal as evidence of your receipt of 
this   
filing.  
  
Very truly yours,  
  
/s/ Daria J. Szczur  
  
Daria J. Szczur  
  
Enclosures  
  
cc:	(with enclosures)  
	John E. Baumgardner, Jr., Esq.		Stephen Brunt  
	Sullivan & Cromwell			Morgan Guaranty Trust Group  
  
	Robert P. Garrett				Michael McCarthy   
	KPMG Peat Marwick LLP 		The Shareholder Services Group Inc.  
  
  
g:\funds\azmu\1996\secdocs\lt.edg
<PAGE>

                                  EXHIBIT 32.1

                  CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
      AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of K-Fed Bancorp (the "Company") on Form
10-Q for the period ending March 31, 2005 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, Kay M. Hoveland, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and in
connection with this quarterly report on Form 10-Q that:

     1.   The Report fully complies with the requirements of sections 13(a) or
          15(d) of the Securities Exchange Act of 1934, as amended, and

     2.   The information contained in the report fairly presents, in all
          material respects, the company's financial condition and results of
          operations.


Date: May 11, 2005                                 /s/ Kay M. Hoveland
      ------------                                 --------------------------
                                                   Kay M. Hoveland
                                                   President and
                                                   Chief Executive Officer
SMITH BARNEY CALIFORNIA MUNICIPALS FUND INC

ARTICLES OF AMENDMENT

	Smith Barney California Municipals Fund Inc., a Maryland 
corporation, having its principal office in Baltimore City, 
Maryland (the "Corporation"), hereby certifies to the State 
Department of Assessments and Taxation of Maryland that:

	FIRST:  The Charter of the Corporation is hereby amended to 
provide that the name of all of the issued and unissued Class C 
Common Stock of the Corporation is hereby changed to Class L Common 
Stock. 

	SECOND:  The foregoing amendment to the Charter of the 
Corporation has been approved by a majority of the entire Board of 
Directors and is limited to a change expressly permitted by Section 
2-605 of the Maryland General Corporation Law to be made without 
action of the stockholders.

	THIRD:  The Corporation is registered as an open-end 
investment company under the Investment Company Act of 1940.

	FOURTH:  The amendment to the Charter of the Corporation 
effected hereby shall become effective at 9:00 a.m. on June 12, 
1998. 

	IN WITNESS WHEREOF, Smith Barney California Municipals Fund 
Inc. has caused these presents to be signed in its name and on its 
behalf by its President and witnessed by its Assistant Secretary as 
of June 1, 1998.


WITNESS:                     SMITH BARNEY CALIFORNIA MUNICIPALS 
                             FUND INC.


/s/Michael Kocur               By: /s/Heath B. McLendon 
Michael Kocur                  Heath B. McLendon
Assistant Secretary            President


THE UNDERSIGNED, President of Smith Barney California Municipals 
Fund Inc., who executed on behalf of the Corporation Articles of 
Amendment of which this Certificate is made a part, hereby 
acknowledges in the name and on behalf of said Corporation the 
foregoing Articles of Amendment to be the corporate act of said 
Corporation and hereby certifies that the matters and facts set 
forth herein with respect to the authorization and approval thereof 
are true in all material respects under the penalties of perjury.


                                /s/ Heath B. McLendon 
                                Heath B. McLendon, President
Exhibit 21



Subsidiaries



|                                                  |  |                                                         |  |                             |  |                                                  |  |                            
|------------------------------------------------- |  | ------------------------------------------------------- |  | --------------------------- |  | ------------------------------------------------ |  | ---------------------------
|Name                                              |  | Place of incorporation
    and kind of
    legal entity |  | Principal activities        |  | Particulars of registered/ paid up share capital |  | Effective interest
    held
|                                                  |  |                                                         |  |                             |  |                                                  |  |                            
|Glamourous Holdings Company Limited (HK)          |  | Hong Kong                                               |  | Entertainment & Consultancy |  | 10,000 ordinary shares at par value of HKD1      |  | 100%                       
|                                                  |  |                                                         |  |                             |  |                                                  |  |                            
|Glamourous Holdings International Company Limited |  | Hong Kong                                               |  | Entertainment & Consultancy |  | 10,000 ordinary shares at par value of  HKD1     |  | 100%
GREENWICH STREET SERIES FUND
on behalf of
Total Return Portfolio (the "Portfolio")

Supplement dated February 25, 1998 to
Prospectus dated April 30, 1997

	The following information supplements, and to the extent 
inconsistent therewith supersedes, the information set forth in the 
Prospectus under "Management of the Fund."

For the investment advisory services provided to it by MMC, the 
Portfolio pays MMC an annual management fee calculated at a rate of 
0.55% of its average daily net assets, paid monthly.  The Portfolio 
also pays MMC an annual administration fee of 0.20% of its average 
daily net assets, paid monthly, for administrative services.








FD 01415
**Exhibit 32.2**

 

**CERTIFICATION PURSUANT TO 18 U.S.C.SECTION 1350**

 

In connectionwith the accompanying quarterly report on Form 10-Q of SuperiorEssex Inc. (the “*Company*”)for the period ended September 30, 2004 (the “*Periodic Report*”), I, David S. Aldridge, Chief FinancialOfficer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, tothe best of my knowledge and belief, that the Periodic Report fully complieswith the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934 and that the information contained in thePeriodic Report fairly presents, in all material respects, the financialcondition and results of operations of the Company.

 
| Date: November 15, 2004 | /s/  DAVID S. ALDRIDGE |   |
|------------------------------|----------------------------------|--------|
|                         | David S. Aldridge                |
| * *                     | *Chief Financial Officer*        |

 

----
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

**1274 KA 14-00720**  PRESENT: SCUDDER, P.J., CENTRA, LINDLEY, VALENTINO, AND WHALEN, JJ.

THE PEOPLE OF THE STATE OF NEW YORK, RESPONDENT,

V MEMORANDUM AND ORDER

KAWAUN VAUGHN, DEFENDANT-APPELLANT.

FRANK H. HISCOCK LEGAL AID SOCIETY, SYRACUSE (EVAN B. HANNAY OF COUNSEL), FOR DEFENDANT-APPELLANT.

WILLIAM J. FITZPATRICK, DISTRICT ATTORNEY, SYRACUSE (JAMES P. MAXWELL OF COUNSEL), FOR RESPONDENT.

Appeal from a judgment of the Onondaga County Court (Joseph E. Fahey, J.), rendered November 10, 2009. The judgment convicted defendant, upon his plea of guilty, of manslaughter in the first degree.
It is hereby ORDERED that the judgment so appealed from is unanimously affirmed.
Memorandum: On appeal from a judgment convicting him upon his plea of guilty of manslaughter in the first degree (Penal Law § 125.20 [1]), defendant contends that the waiver of the right to appeal is not valid and challenges the severity of the sentence. Although “[w]e agree with defendant that the waiver of the right to appeal is invalid because the minimal inquiry made by County Court was insufficient to establish that the court engage[d] the defendant in an adequate colloquy to ensure that the waiver of the right to appeal was a knowing and voluntary choice” ( People v Jones , 107 AD3d 1589, 1589, lv denied 21 NY3d 1075 [internal quotation marks omitted]; see People v Hassett , 119 AD3d 1443, 1443-1444, lv denied 24 NY3d 961; People v Mobley , 118 AD3d 1336, 1336-1337, lv denied 24 NY3d 1121), we nevertheless reject defendant’s challenge to the severity of the sentence.

Entered: December 23, 2015 Frances E. Cafarell Clerk of the Court